1. Home
  2. CELU vs AERT Comparison

CELU vs AERT Comparison

Compare CELU & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • AERT
  • Stock Information
  • Founded
  • CELU 2016
  • AERT 2012
  • Country
  • CELU United States
  • AERT Singapore
  • Employees
  • CELU N/A
  • AERT N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • CELU Health Care
  • AERT Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • AERT Nasdaq
  • Market Cap
  • CELU 42.2M
  • AERT 37.6M
  • IPO Year
  • CELU N/A
  • AERT N/A
  • Fundamental
  • Price
  • CELU $3.86
  • AERT $0.71
  • Analyst Decision
  • CELU Buy
  • AERT
  • Analyst Count
  • CELU 1
  • AERT 0
  • Target Price
  • CELU $6.00
  • AERT N/A
  • AVG Volume (30 Days)
  • CELU 66.2K
  • AERT 7.1M
  • Earning Date
  • CELU 10-15-2025
  • AERT 08-14-2025
  • Dividend Yield
  • CELU N/A
  • AERT N/A
  • EPS Growth
  • CELU N/A
  • AERT N/A
  • EPS
  • CELU N/A
  • AERT N/A
  • Revenue
  • CELU $44,590,000.00
  • AERT $68,861,000.00
  • Revenue This Year
  • CELU $23.29
  • AERT N/A
  • Revenue Next Year
  • CELU N/A
  • AERT N/A
  • P/E Ratio
  • CELU N/A
  • AERT N/A
  • Revenue Growth
  • CELU 138.11
  • AERT N/A
  • 52 Week Low
  • CELU $1.00
  • AERT $0.46
  • 52 Week High
  • CELU $5.22
  • AERT $2.80
  • Technical
  • Relative Strength Index (RSI)
  • CELU 60.90
  • AERT 42.84
  • Support Level
  • CELU $3.52
  • AERT $0.74
  • Resistance Level
  • CELU $4.01
  • AERT $0.92
  • Average True Range (ATR)
  • CELU 0.34
  • AERT 0.15
  • MACD
  • CELU -0.01
  • AERT -0.01
  • Stochastic Oscillator
  • CELU 64.84
  • AERT 15.22

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: